Axsome Therapeutics Inc (NASDAQ:AXSM)

64.90
Delayed Data
As of 3:59pm ET
 -1.17 / -1.76%
Today’s Change
35.44
Today|||52-Week Range
109.53
-20.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization13.1K12.2K11.4K11.1K
 
 
 
 
 
 
Operating ExpensesGross Income-13.1K-12.2K-11.4K-11.1K
 
 
 
 
 
General Expenses8.2M9.4M10.4M13.4M
 
 
 
 
 
Research And Development6.0M7.2M7.6M11.0M
 
 
 
 
 
Total Operating Expenses8.2M9.5M10.4M13.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.2M-9.5M-10.4M-13.4M
 
 
 
 
 
Extraordinary Credit15.0K102.0K0.000.00
 
 
 
Interest Expense On Debt270.9K248.7K218.9K314.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.5M-9.6M-10.6M-13.8M
 
 
 
 
 
Income Taxes-217.4K0.000.000.00
 
 
Net Income-8.3M-9.6M-10.6M-13.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.3M29.9M33.1M33.8M
 
 
 
 
 
Shares To Calculate EPS Diluted26.3M29.9M33.1M33.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.32-$0.32-$0.41
 
 
 
 
 
EPS Diluted-$0.31-$0.32-$0.32-$0.41